Revenue Growth
Revenue increased by $60.6 million or 20% compared to the same period last year, with revenue for Q1 2024 at $364.3 million.
Expansion and Acquisitions
Completed 2 practice acquisitions in Q1 and announced 2 additional acquisitions in Q2, expanding presence in Texas, Maryland, Hawaii, and Georgia.
Provider Network Growth
Added 17 new providers in Q1 and a total of 40 year-to-date, strengthening the platform.
Launch of MiBA
Introduced Meaningful Insights Biotech Analytics to enhance personalized cancer care and patient outcomes using AI technologies.
High Net Promoter Scores
Achieved Net Promoter Scores of 75% or greater from physicians and team members, and over 90% from patients.